competitive radioligand binding assays using recombinant human cannabinoid receptors expressed in chem-1 and cho cells identified (-)-epigallocatechin-3-o-gallate, egcg (k(i)=33.6 microm), (-)-epigallocatechin, egc (k(i)=35.7 microm), and (-)-epicatechin-3-o-gallate, ecg (k(i)=47.3 microm) as ligands with moderate affinity for type 1 cannabinoid receptors, cb1.